Feasibility of complex coronary intervention in combination with percutaneous aortic valve implantation in patients with aortic stenosis using percutaneous left ventricular assist device (TandemHeart®)

Catheterization and Cardiovascular Interventions

Volumn 73, Issue 2, 2009, Pages 161-166

  Piazza, Nicolo ^a   Serruys, Patrick W ^a   de Jaegere, Peter ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Aortic stenosis; Left main coronary disease; Percutaneous coronary intervention; Total occlusions; Transcatheter; Valvular heart disease

Indexed keywords

AGED; ANGINA PECTORIS; ANGIOCARDIOGRAPHY; AORTA VALVE REPLACEMENT; AORTA VALVE STENOSIS; ARTICLE; CASE REPORT; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; DYSPNEA; ELECTROCARDIOGRAPHY; FEMALE; HEART FAILURE; HEART INFARCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART VALVE BIOPROSTHESIS; HIGH RISK PATIENT; HUMAN; PERCUTANEOUS CORONARY INTERVENTION; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PHYSICAL EXAMINATION; SURGICAL RISK; SURGICAL TECHNIQUE; TRANSLUMINAL VALVULOPLASTY; VASCULAR ACCESS DEVICE;

AGED, 80 AND OVER; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; AORTIC VALVE STENOSIS; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; EQUIPMENT DESIGN; FEASIBILITY STUDIES; FEMALE; HEART VALVE PROSTHESIS; HEART VALVE PROSTHESIS IMPLANTATION; HEART-ASSIST DEVICES; HEMODYNAMICS; HUMANS; MALE; PROSTHESIS DESIGN; SEVERITY OF ILLNESS INDEX; STENTS; TREATMENT OUTCOME;

EID: 60649121987     PISSN: 15221946     EISSN: 1522726X     Source Type: Journal    
DOI: 10.1002/ccd.21843     Document Type: Article

References (19)

1. Ortlepp JR, Schmitz F, Bozoglu T, Hanrath P, Hoffmann R. Cardiovascular risk factors in patients with aortic stenosis predict prevalence of coronary artery disease but not of aortic stenosis: An angiographic pair matched case-control study. Heart 2003;89:1019-1022.
2. Mohler ER, Sheridan MJ, Nichols R, Harvey WP, Waller BF. Development and progression of aortic valve stenosis: Atherosclerosis risk factors - A causal relationship? A clinical morphologic study. Clin Cardiol 1991;14:995-999.
3. Vahanian A, Baumgartner H, Bax J, Butchart E, Dion R, et al. Guidelines on the management of valvular heart disease: The Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology. Eur Heart J 2007;28:230-268.
4. Bonow RO, Carabello BA, Chatterjee K, de Leon AC Jr, Faxon DP, et al. ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing Committee to Revise the 1998 guidelines for the management of patients with valvular heart disease) developed in collaboration with the Society of Cardiovascular Anesthesiologists endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons. J Am Coll Cardiol 2006;48:e1-e148.
5. Herlitz J, Brandrup-Wognsen G, Caidahl K, Haglid M, Karlsson BW, Karlsson T, Albertsson P, Lindelow B. Mortality and morbidity among patients who undergo combined valve and coronary artery bypass surgery: Early and late results. Eur J Cardiothorac Surg 1997;12:836-846.
6. Brinster DR, Byrne M, Rogers CD, Baim DS, Simon DI, Couper GS, Cohn LH. Effectiveness of same day percutaneous coronary intervention followed by minimally invasive aortic valve replacement for aortic stenosis and moderate coronary disease ("hybrid approach"). Am J Cardiol 2006;98:1501-1503.
7. Pedersen WR, Klaassen PJ, Pedersen CW, Wilson JA, Harris KM, Goldenberg IF, Poulose AK, Mooney MR, Henry TD, Schwartz RS. Comparison of outcomes in high-risk patients >70 years of age with aortic valvuloplasty and percutaneous coronary intervention versus aortic valvuloplasty alone. Am J Cardiol 2008;101:1309-1314.
8. Cribier A, Eltchaninoff H, Tron C, Bauer F, Agatiello C, Nercolini D, Tapiero S, Litzler PY, Bessou JP, Babaliaros V. Treatment of calcific aortic stenosis with the percutaneous heart valve: Mid-term follow-up from the initial feasibility studies: The French experience. J Am Coll Cardiol 2006;47:1214-1223.
9. Webb JG, Pasupati S, Humphries K, Thompson C, Altwegg L, et al. Percutaneous transarterial aortic valve replacement in selected high-risk patients with aortic stenosis. Circulation 2007; 116:755-763.
10. Grube E, Schuler G, Buellesfeld L, Gerckens U, Linke A, et al. Percutaneous aortic valve replacement for severe aortic stenosis in high-risk patients using the second- and current third-generation self-expanding Core Valve prosthesis: Device success and 30-day clinical outcome. J Am Coll Cardiol 2007; 50:69-76.
11. Piazza N, Grube E, Gerckens U, den Heijer P, Linke A, et al. Procedural and 30-day outcomes following transcatheter aortic valve implantation using the third generation (18F) CoreValve ReValving System - Results from the Multicenter, Expanded Evaluation Registry 1-year following CE mark approval. Eurointervention 2008;4:242-249.
12. de Jaegere P, van Dijk L, Laborde JC, Sianos G, Ramos FJO, Lighart J, Kappetein AP, vander Ent M, Serruys PW. True percutaneous implantation of the CoreValve aortic valve prosthesis by the combined use of ultrasound guided vascular access, Prostar XL and the TandemHeart. Eurointervention 2007;2:500-505.
13. Sianos G, Morel MA, Kappetein AP, Morice MC, Colombo A, et al. The SYNTAX Score: An angiographic tool grading the complexity of coronary artery disease. Eurointervention 2005;2: 219-227.
14. Nashef SA, Roques F, Michel P, Gauducheau E, Lemeshow S, Salamon R. European system for cardiac operative risk evaluation (EuroSCORE). Eur J Cardiothorac Surg 1999;16:9-13.
15. Subramanian H, Kunadian B, Dunning J. Is it ever worth contemplating an aortic valve replacement on patients with low gradient severe aortic stenosis but poor left ventricular function with no contractile reserve? Interact Cardiovasc Thorac Surg 2008;7:301-305.
16. Vranckx P, Foley DP, de Feijter PJ, Vos J, Smits P, Serruys PW. Clinical introduction of the Tandemheart, a percutaneous left ventricular assist device, for circulatory support during high-risk percutaneous coronary intervention. Int J Cardiovasc Interv 2003;5:35-39.
17. Vandormael M, Deligonul U, Gabliani G, Chaitman B, Kern MJ. Percutaneous balloon valvuloplasty and coronary angioplasty for the treatment of calcific aortic stenosis and obstructive coronary artery disease in an elderly patient. Cathet Cardiovasc Diagn 1988;14:49-52.
18. McKay RG, Safian RD, Berman AD, Diver DJ, Weinstein JS, Wyman RM, Cunningham MJ, McKay LL, Baim DS, Grossman W. Combined percutaneous aortic valvuloplasty and transluminal coronary angioplasty in adult patients with calcific aortic stenosis and coronary artery disease. Circulation 1987;76:1298-1306.
19. Alcalai R, Viola N, Mosseri M, Beeri R, Leibowitz D, Lotan C, Gilon D. The value of percutaneous coronary intervention in aortic valve stenosis with coronary artery disease. Am J Med 2007;120:185 e7-185 e13.